Talphera TLPH
NASDAQ TLPH
$1.24 +0.01 (+1.23%)
As of: Sep 10, 2026 · 1:39 PM EDT

Talphera (TLPH) Shares Outstanding (2010 - 2026)

Talphera (TLPH) posted Shares Outstanding (Entity) of $75.5 million for Q2 2026, up 8.17% on a QoQ basis from $69.8 million in Q1 2026, and up 118.73% year-over-year from $34.5 million in Q2 2025.

Analysis

Talphera (TLPH) Shares Outstanding (2010 - 2026) Analysis & Trends

Talphera has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $75.5 million in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 118.73% year-over-year to $75.5 million in Q2 2026; TTM through Jun 2026 was $75.5 million, a 118.73% increase from a year earlier, with the FY2025 full-year figure at $49.3 million, up 90.86% from the prior year.
  • Shares Outstanding (Entity) was $75.5 million for Q2 2026 at Talphera, up from $69.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $75.5 million in Q2 2026, with the low at $7.4 million in Q1 2022.
  • Average Shares Outstanding (Entity) over 5 years is $27.2 million, with a median of $25.3 million recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) climbed 6.25% in 2025, then surged 165.8% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $8.2 million in 2022, then surged by 105.64% to $17.0 million in 2023, then soared by 52.46% to $25.8 million in 2024, then surged by 90.86% to $49.3 million in 2025, then jumped by 53.11% to $75.5 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $75.5 million (Q2 2026), $69.8 million (Q1 2026), and $49.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 180.02 Bn 176.84 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 131.54 Bn 123.69 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 81.96 Bn 73.96 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 60.23 Bn 55.04 Bn 1.37 Bn 61.30 Mn
6 Moderna 53.85 Bn 48.72 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 33.13 Bn 29.82 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.88 Bn 30.59 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.23 Bn 29.23 Bn 1.16 Mn 720.78 Mn
10 Talphera 93.28 Mn 93.28 Mn - 75.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.53 Mn
Mar 31, 2026 69.82 Mn
Dec 31, 2025 42.41 Mn
Sep 30, 2025 41.45 Mn
Jun 30, 2025 34.53 Mn
Mar 31, 2025 26.27 Mn
Dec 31, 2024 25.85 Mn
Sep 30, 2024 26.21 Mn
Jun 30, 2024 26.20 Mn
Mar 31, 2024 24.72 Mn
Dec 31, 2023 14.26 Mn
Sep 30, 2023 16.76 Mn
Jun 30, 2023 10.92 Mn
Mar 31, 2023 10.89 Mn
Dec 31, 2022 7.39 Mn
Sep 30, 2022 7.38 Mn
Jun 30, 2022 7.36 Mn
Mar 31, 2022 7.28 Mn
Dec 31, 2021 5.99 Mn
Sep 30, 2021 5.96 Mn